Limits to Governance
-15%
portes grátis
Limits to Governance
The Challenge of Policy-Making for the New Life Sciences
Lyall, Catherine; Papaioannou, Theo
Taylor & Francis Ltd
06/2009
300
Dura
Inglês
9780754675082
15 a 20 dias
453
Descrição não disponível.
Contents: Foreword; Preface; The challenge of policy-making for the new life sciences, Catherine Lyall, Theo Papaioannou and James Smith; Part 1 Principles: Governance and justice: the challenge of genomics, Theo Papaioannu; The roles of values and interests in the governance of the life sciences: learning lessons from the 'ethics+' approach of UK Biobank, Graeme Laurie, Ann Bruce and Catherine Lyall; Governing reproductive treatment and research: from the moral to the political to the legal - and back again? Or 'there and back again, a regulator's (Hobbit's) odyssey (holiday)', Shawn H.E. Harmon. Part 2 Processes: Evolution along the government-governance continuum: impacts of regulations on medicines innovation in the United States, Christopher-Paul Milne and Joyce Tait; Governments and governance of bioscience as a 'new security challenge', Paul Nightingale and CaitrA-ona McLeish; Biosciences, 'development' and the abstraction of governance, James Smith; Ever-changing policy context: the one stable threat to biotech governance in Africa?, Julius Tazvishaya Mugwagwa. Part 3 People: Advocacy groups as research organizations: novel approaches in research governance, Nadja Kanellopoulou; Non-governmental limits: governing biotechnology from Europe to Africa, Matthew Harsh; Deliberative governance: political fad or a vision of empowerment?, Peter Bryant; Governance in action in the life sciences: some lessons for policy, Catherine Lyall, Theo Papaioannou and James Smith; Index.
Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.
crops;agenda;life;sciences;biobank;patient;advocacy;groups;innovation;biosecurity;National DNA Database;Public Engagement;UK Human Fertilisation;Contemporary UK Society;Life Sciences Innovation;Public Private Partnerships;Gm Crop;UK Government's Department;Fast Track Designation;Miami Children's Hospital;Procreative Beneficence;Biosecurity Policy;Gm Food;Socioeconomic Development;Patient Advocacy Groups;Fast Track Products;HFEA;Genetic Discrimination;Gm Food Aid;Socio-economic Development;Kidney Cancer Association;UNEP Workshop;Pre-implantation Genetic Diagnosis;Civil Society;Uncertainty Avoidance
Contents: Foreword; Preface; The challenge of policy-making for the new life sciences, Catherine Lyall, Theo Papaioannou and James Smith; Part 1 Principles: Governance and justice: the challenge of genomics, Theo Papaioannu; The roles of values and interests in the governance of the life sciences: learning lessons from the 'ethics+' approach of UK Biobank, Graeme Laurie, Ann Bruce and Catherine Lyall; Governing reproductive treatment and research: from the moral to the political to the legal - and back again? Or 'there and back again, a regulator's (Hobbit's) odyssey (holiday)', Shawn H.E. Harmon. Part 2 Processes: Evolution along the government-governance continuum: impacts of regulations on medicines innovation in the United States, Christopher-Paul Milne and Joyce Tait; Governments and governance of bioscience as a 'new security challenge', Paul Nightingale and CaitrA-ona McLeish; Biosciences, 'development' and the abstraction of governance, James Smith; Ever-changing policy context: the one stable threat to biotech governance in Africa?, Julius Tazvishaya Mugwagwa. Part 3 People: Advocacy groups as research organizations: novel approaches in research governance, Nadja Kanellopoulou; Non-governmental limits: governing biotechnology from Europe to Africa, Matthew Harsh; Deliberative governance: political fad or a vision of empowerment?, Peter Bryant; Governance in action in the life sciences: some lessons for policy, Catherine Lyall, Theo Papaioannou and James Smith; Index.
Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.
crops;agenda;life;sciences;biobank;patient;advocacy;groups;innovation;biosecurity;National DNA Database;Public Engagement;UK Human Fertilisation;Contemporary UK Society;Life Sciences Innovation;Public Private Partnerships;Gm Crop;UK Government's Department;Fast Track Designation;Miami Children's Hospital;Procreative Beneficence;Biosecurity Policy;Gm Food;Socioeconomic Development;Patient Advocacy Groups;Fast Track Products;HFEA;Genetic Discrimination;Gm Food Aid;Socio-economic Development;Kidney Cancer Association;UNEP Workshop;Pre-implantation Genetic Diagnosis;Civil Society;Uncertainty Avoidance
